Mark Naccarato

发表

Amiodarone and Concurrent Antiretroviral Therapy: A Case Report and Review of the Literature

I. Fong, D. Yoong, Mark Naccarato, 2014, Antiviral therapy.

A Potential Drug–Herbal Interaction between Ginkgo biloba and Efavirenz

K. Gough, D. Yoong, Mark Naccarato, 2012, Journal of the International Association of Physicians in AIDS Care.

Use of Compassionate Supply of Antiretroviral Drugs to Avoid Treatment Interruptions or Delayed Treatment Initiation among HIV-Positive Patients Living in Ontario: A Retrospective Review.

A. Bayoumi, K. Gough, D. Yoong, 2015, Healthcare policy = Politiques de sante.

Selecting an Antiretroviral Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis in the Occupational Setting

K. Gough, D. Yoong, Mark Naccarato, 2014, Infection Control & Hospital Epidemiology.

Omega-3-enriched lipid emulsion for liver salvage in parenteral nutrition-induced cholestasis in the adult patient.

K. Jeejeebhoy, G. Gardiner, B. Jurewitsch, 2011, JPEN. Journal of parenteral and enteral nutrition.

Extensive Bruising and Elevated Rivaroxaban Plasma Concentration in a Patient Receiving Cobicistat-Boosted Elvitegravir

K. Gough, D. Yoong, Mark Naccarato, 2017, The Annals of pharmacotherapy.

Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?

I. Fong, J. Zaltzman, Mark Naccarato, 2021, AIDS.

High prevalence of syndemic health problems in patients seeking post-exposure prophylaxis for sexual exposures to HIV

I. Bogoch, T. Hart, S. Morrison, 2018, PloS one.

The PrEP You Want: A Web-Based Survey of Online Cross-Border Shopping for HIV Prophylaxis Medications

B. Walmsley, M. Hull, Mark Naccarato, 2019, Journal of medical Internet research.

Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis

J. Wilton, Heather Senn, Malika Sharma, 2016, International journal of STD & AIDS.

The PrEP You Want: A Web-Based Survey of Online Cross-Border Shopping for HIV Prophylaxis Medications

Daniel Gallant, B. Walmsley, M. Hull, 2018, Journal of medical Internet research.

Re: “Erythema Annulare Centrifugum due to Pegylated Interferon-α-2a plus Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C Virus Infection”

M. Ostrowski, D. Yoong, Mark Naccarato, 2015, Journal of cutaneous medicine and surgery.

Dolutegravir and metformin: a case of hyperlactatemia.

I. Fong, D. Yoong, Mark Naccarato, 2017, AIDS.

and Efavirenz Ginkgo biloba Herbal Interaction between − A Potential Drug

K. Gough, D. Yoong, Mark Naccarato, 2012 .

A Case of a Potential Drug Interaction between Phenobarbital andDarunavir-based Antiretroviral Therapy

I. Fong, K. Gough, D. Yoong, 2016 .

A Case of a Potential Drug Interaction between Clobazam and Etravirine-Based Antiretroviral Therapy

C. Kovacs, K. Gough, D. Yoong, 2012, Antiviral Therapy.

Feasibility of implementing a same-day electronic screening tool for clinical assessment to measure patient-reported outcomes for eliciting actionable information on adherence to HIV medication and related factors in a busy Canadian urban HIV clinic

H. Crane, R. Fredericksen, K. Gough, 2021, International journal of STD & AIDS.

A Case of a Probable drug Interaction between Lurasidone and Atazanavir-Based Antiretroviral Therapy

M. Ostrowski, Elise Hall, A. Carvalhal, 2016, Antiviral therapy.

Combination Therapy with Tenofovir Disoproxil Fumarate/Emtricitabine/Elvitegravir/Cobicistat Plus Darunavir Once Daily in Antiretroviral-Naive and Treatment-Experienced Patients: A Retrospective Review

I. Fong, K. Gough, D. Yoong, 2018, Journal of the International Association of Providers of AIDS Care.

Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series.

C. Brumme, Mark Naccarato, D. Tan, 2023, HIV medicine.